RPN2 and breast carcinoma: A recent study identified ribophorin II (RPN2), part of an N-oligosaccharyl transferase complex, as a novel regulator of drug resistance via the regulation of the N-linked glycosylation of ABCB1 (P-glycoprotein) in breast cancer [107].